https://www.marketscreener.com/quote/stock/GEOVAX-LABS-INC-112977270/news/Geovax-Reports-Positive-Interim-Data-from-Phase-2-Clinical-Trial-of-Geo-Cm04s1-as-A-Universal-Covid-45898104/?utm_source=telegram&utm_medium=social&utm_campaign=share